Company / Current Assets
Voyager Therapeutics, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$202.7M
FY2025
5-year range
$124.5M / $319.7M
FY2021-FY2025
Trend
-26.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $124M in FY2022 to $320M in FY2023.
Based on SEC 10-K filings.
$203M in FY2025 with a 5-year CAGR of +0.5%.
Declined from $320M to $203M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +0.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +0.5%, indicating consistent growth.
- In FY2025, current assets decreased 26.8% year-over-year.
- Peak current assets was recorded in FY2023.
- Lowest current assets in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $202.7M | -26.8% |
| FY2024 | $276.8M | -13.4% |
| FY2023 | $319.7M | +156.8% |
| FY2022 | $124.5M | -8.9% |
| FY2021 | $136.7M | -30.9% |
| FY2020 | $197.8M | -35.1% |
| FY2019 | $304.7M | +87.5% |
| FY2018 | $162.5M | -5.4% |
| FY2017 | $171.8M | -3.9% |
| FY2016 | $178.8M | -8.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026